Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial

INTRODUCTION: Acute bronchitis is a self-limiting infection of the large airways; cough is the primary symptom, usually lasting for about 3 weeks. Annually, approximately 5% of adults develop acute bronchitis, and its economic burden is substantial. There are also problems of antibiotic abuse in pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Yee Ran, Yang, Won-Kyung, Park, So Jung, Kim, Seung-Hyeong, Kang, Wee-Chang, Jung, In Chul, Park, Yang Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961554/
https://www.ncbi.nlm.nih.gov/pubmed/29764875
http://dx.doi.org/10.1136/bmjopen-2017-019897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961554/
https://www.ncbi.nlm.nih.gov/pubmed/29764875
http://dx.doi.org/10.1136/bmjopen-2017-019897

Ejemplares similares